ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Long-Term Analysis of Combined Liver-Lung Transplant Outcomes at a Single-Center.

K. Freischlag,1 B. Ezekian,2 M. Mulvihill,2 S. Knechtle.2

1School of Medicine, Duke University, Durham, NC
2Surgery, Duke University, Durham, NC

Meeting: 2017 American Transplant Congress

Abstract number: B254

Keywords: Liver transplantation, Lung transplantation, Outcome, Survival

Session Information

Date: Sunday, April 30, 2017

Session Name: Poster Session B: Lung Transplantation Poster Session

Session Time: 6:00pm-7:00pm

 Presentation Time: 6:00pm-7:00pm

Location: Hall D1

Related Abstracts
  • Combined Lung and Liver Transplantation: Analysis of a Single-Center Experience
  • Outcomes of Combined Liver/Lung Transplantation for Cystic Fibrosis Using SRTR Analysis.

Purpose: Combined liver-lung transplantation (CLLT) is indicated in patients who would not be expected to survive transplantation of either organ alone. We present one of the largest and most recent series to date.

Methods: The UNOS database was queried for patients that underwent CLLT at our institution from 2000-2016. Statistical analysis was performed using R. Survival was plotted using the Kaplan-Meier method.

Results: Our hospital performed 12 CLLTs from 2000-2016. There were 9 male and 3 female recipients with a mean age of 33.7 years and BMI of 21. Indications for lung transplantation were cystic fibrosis (8), idiopathic pulmonary fibrosis (3), and pulmonary fibrosis secondary to hepatopulmonary syndrome (1). Indications for liver transplantation were cystic fibrosis (8), alcoholic cirrhosis (1), idiopathic cirrhosis (1), hepatoportal sclerosis (1), and alpha-1 antitrypsin deficiency (1). Average FEV1 at transplant was 27.8% and average MELD was 10.5. Median hospital stay was 44.5 days post-transplant. Overall patient survival percentage was 100% at 30 days, 90.9% at 1 year, and 62.5% at 3 years. At the time of analysis, 7 of 12 patients were alive with three patients alive at over 8 years post-CLLT. Three patients required lung re-transplantation. Of the deceased patients, the causes of death were primary graft failure (1), bronchiolitis obliterans syndrome (1), large cell lung adenocarcinoma (1), cholestatic liver disease and pneumonia (1), and squamous cell carcinoma of the eyelid and systemic nocardia (1).

Conclusions: An improved understanding of outcomes following CLLT is imperative to determine whether dual allocation of organs to a single recipient is justifiable. Here we present one of the largest US single-institution series, which showed that CLLT had a similar long-term survival rate to other major CLLT series and isolated lung transplantation. This complex procedure, however, carries a significant risk of morbidity and mortality, even at the most experienced centers. Large database analysis will be helpful in determining the future of organ allocation in this unique population.

CITATION INFORMATION: Freischlag K, Ezekian B, Mulvihill M, Knechtle S. Long-Term Analysis of Combined Liver-Lung Transplant Outcomes at a Single-Center. Am J Transplant. 2017;17 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Freischlag K, Ezekian B, Mulvihill M, Knechtle S. Long-Term Analysis of Combined Liver-Lung Transplant Outcomes at a Single-Center. [abstract]. Am J Transplant. 2017; 17 (suppl 3). https://atcmeetingabstracts.com/abstract/long-term-analysis-of-combined-liver-lung-transplant-outcomes-at-a-single-center/. Accessed April 23, 2021.

« Back to 2017 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Deceased Non-A2 Donor ABO-Incompatible Liver Transplantation – Promising Results with Anti-A/B Antibody Reduction Both Pre- and Post-Transplant.
  • Penis Transplantation: First U.S. Experience.
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Penis Transplantation: First U.S. Experience.
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.